JX2105

· Zhejiang Jingxin Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JX2105, covering 2024-08-05 to 2024-08-05. Get the full timeline:

Most recent: Clinical Trial Update: A Randomized, Double-blind, Placebo-controlled Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of JX2105 in Healthy Chinese Subjects [Phase 1]

See pricing